NL-OMON39945已完成不适用
ENHANCED device programming to reduce therapies and improve quality of life in Implantable Cardioverter Defibrillator patients: A prospective, single-arm safety monitoring study - ENHANCED-ICD study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients implanted with a Medtronic ProtectaTM ICD (VR or DR) or CRT-D, between 18-80 years of age, with a primary or secondary prophylactic indication for ICD therapy according to the current European guidelines, speaking and understanding Dutch, and providing written informed consent will be eligible to participate.
排除标准
- •Patients with a life expectancy less than 1 year, with a history of psychiatric illness other than affective/anxiety disorders, on the waiting list for heart transplantation or with insufficient knowledge of the Dutch language will be excluded.
研究者
相似试验
Unknown
不适用
ENHANCED Device Programming to Reduce Therapies and Improve Quality of Life in Implantable Cardioverter Defibrillator (ICD) PatientsCardiac ArrhythmiasNCT01715116M. Meine60
尚未招募
Unknown
Pharmaceutical guidance for optimizing the use of asthma medicationsAsthmaRBR-9kkjvnjniversidade Federal do Rio Grande do Norte
已完成
不适用
Rational use of substrate reduction therapy and enzyme replacement therapy in patients with type I Gaucher disease (Uso racional de los tratamientos por inhibición de sustrato y enzimático sustitutivo en pacientes con enfermedad de Gaucher tipo I)Type I Gaucher?s diseaseNutritional, Metabolic, EndocrineDisorders of sphingolipid metabolism and other lipid storage disordersISRCTN05147495Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)40
招募中
不适用
Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patientsend stage renal diseaseJPRN-UMIN000020384second department of internal medicine, Kansai Medical University Hirakata hospital100
已完成
4 期
Efficacy of the tissue press method for reducing systemic side effects of eye drops compared to nasolacrimal occlusioACTRN12616000404426uzia Mueller20